<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://newdrugapprovals.org/2026/07/13/olisutrigine-bromide/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-13T02:33:00+00:00</news:publication_date><news:title>Olisutrigine bromide</news:title><news:keywords>analgesic, sodium channel blocker, anax labs, EN 3427, ASN008, olisutrigine bromide, ASN 008</news:keywords></news:news></url><url><loc>https://newdrugapprovals.org/2026/07/12/netanasvir/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-12T02:30:51+00:00</news:publication_date><news:title>Netanasvir</news:title><news:keywords>HCV, antiviral, APPROVALS 2025, CHINA 2025, anax labs, netanasvir, Dongweizhuo, HEC 74647 PA, Antaitavir Hasophate</news:keywords></news:news></url></urlset>
